Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The study compared the relative bioavailability (rate and extent of absorption) of 10 mg
Zolpidem tablets by Ohm Laboratories Inc. with that of 10 mg Ambien® tablets distributed by
Sanofi-Synthelabo, Inc. following single oral dose (1x10 mg tablet) in healthy adult
volunteers administered under fasting condition